Reference
Erman A, et al. Pharmacotherapy versus surgery as initial therapy for patients with moderate-to-severe benign prostate hyperplasia: a cost-effectiveness analysis. BJU International : 16 Aug 2018. Available from: URL: http://doi.org/10.1111/bju.14520
Rights and permissions
About this article
Cite this article
Benign prostate hyperplasia: pharmacotherapy vs surgery. PharmacoEcon Outcomes News 811, 5 (2018). https://doi.org/10.1007/s40274-018-5234-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5234-2